Maher Naaman Madhat

US Patent:

20030045577, Mar 6, 2003

Filed:

Aug 15, 2001

Appl. No.:

09/930399

Inventors:

Maher Madhat - Lexington KY, US

International Classification:

A61K031/20
A61K031/13

US Classification:

514/558000, 514/560000, 514/662000

Abstract:

A method and composition for treating patients with viral infection with pharmaceutical agents is disclosed. In one embodiment, the virus is influenza A and the pharmaceutical agent is rimantadine or amantadine. The methods of the present invention can be used as a way of eradicating influenza virus topically by direct administration of a dose—nasally—that is much lower than an oral therapeutic dose. Thereby avoiding the side effects associated with oral administration. Consequently, the low dose of the drug administered by this method will be well tolerated among age groups

US Patent:

20030131435, Jul 17, 2003

Filed:

Jan 15, 2002

Appl. No.:

10/050356

Inventors:

Maher Madhat - Lexington KY, US

International Classification:

A47L009/14

US Classification:

015/246200, 015/347000, 015/327500

Abstract:

The aforesaid and other objectives are realized providing a preferred embodiment of a lawn vacuum attachment having a bag with wheels positioned at the opposing sides thereof to allow the attachment to be rolled along a lawn or other surface. With the attachment so connected, the user can manually roll the attachment over the lawn instead of carrying it while holding the lawn vacuum machine as it operates.

US Patent:

62649744, Jul 24, 2001

Filed:

Jul 7, 1998

Appl. No.:

9/111550

Inventors:

Maher N. Madhat - Lexington KY

International Classification:

A61F 1300

US Classification:

424434

Abstract:

Physostigmine, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5ol methylcarbamate, administered buccally or sublingually in non-sustained release dosage form provides extremely prolonged blood levels. This active agent is physically compounded with materials of some or all of classes of ingredients that function as pH controls, preservative agents, viscosity control agents, absorption enhancers, stabilizing agents, solvents, and carrier vehicles. This compounding will produce a pharmaceutical composition in the form of a liquid, tablet, gel, patch or lozenge for administration of the active agent, Physostigmine, by absorption through the buccal or sublingual mucosa of the patient. This method of delivery of Physostigmine and similar compounds is useful for treatment of cognitive deficiencies and/or neurological function deficits, mood and/or mental disturbances in mammals including human beings.

US Patent:

60953268, Aug 1, 2000

Filed:

Jun 21, 1999

Appl. No.:

9/337721

Inventors:

Maher N. Madhat - Lexington KY
Munir A. Hussain - Wilmington DE

International Classification:

B65D 7100

US Classification:

206233

Abstract:

Packaging of disposable gloves with consumer tissue products in order: To provide first aid protection (disposable gloves) in every type of package of consumer tissue products, and To utilize the widely used consumer tissue products as a vehicle to deliver the disposable gloves to end user. A new package form for consumer tissue products and particularly facial tissue for containing infectious body fluids resulting from the said injuries comprising: a) Any form of consumer package tissue products, b) One or more protective disposable gloves, c) Said gloves package having dimensions allowing said package to be incorporated in any existing forms and shapes of consumer tissue products and particularly facial tissue.